SMS Pharmaceuticals
add_icon

SMS Pharmaceuticals

356.50
-7.45
(-2.05%)
Market Cap
3,338.70 Cr
PE Ratio
32.72
Volume
1,63,360.00
Day High - Low
364.60 - 352.70
52W High-Low
447.80 - 207.70
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
3,338.70 Cr
EPS
11.15
PE Ratio
32.72
PB Ratio
4.25
Book Value
83.91
EBITDA
171.28
Dividend Yield
0.11 %
Industry
Healthcare
Return on Equity
10.54
Debt to Equity
0.50
Forecast For
Actual

Company News

View All News
Caret
neutral
SMS Pharmaceuticals Ltd will hold an investor conference call on May 27, 2026, at 11 am IST to discuss Q4 and FY26 results.
neutral
SMS Pharmaceuticals has scheduled a Board of Directors meeting on May 22, 2026, to approve audited financials for Q4 and FY2025-26, and consider dividend recommendation.
neutral
SMS Pharmaceuticals Limited published newspaper advertisements about IEPFA's Second 100-Days Campaign 'Saksham Niveshak' for investor education and protection fund compliance, scheduled from April 1 to July 9, 2026.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,788.50
#1 4,29,121.10
37.30
#1 58,220.10
6.38
#1 11,565
25.80
44.37
6,576.50
1,74,585.40
67.97
10,560.00
8.73
2,520
13.44
46.75
4,368.50
1,47,849.90
69.16
13,886.20
20.34
2,138
-26.91
50.11
1,375.20
1,11,086.00
28.76
27,711.70
-2.46
3,783
-55.32
52.65
1,076.60
1,08,331.20
21.14
26,719.70
13.65
5,242
7.82
68.91
1,263.30
1,05,440.50
25.35
33,593.30
-0.44
3,998
-86.05
41.47
2,261.20
1,03,346.60
#1 19.30
27,487.50
19.98
5,345
#1 87.72
45.17
2,369.50
97,814.20
50.52
14,277.60
12.03
1,750
31.75
50.42
1,440.40
83,658.70
23.88
33,384.70
3.21
3,376
1.99
48.90
1,394.30
75,272.20
84.57
6,812.90
#1 21.03
884
21.18
76.00
Growth Rate
Revenue Growth
12.40 %
Net Income Growth
34.58 %
Cash Flow Change
63.03 %
ROE
14.94 %
ROCE
5.02 %
EBITDA Margin (Avg.)
3.91 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
126
136
102
105
118
119
81
100
114
131
150
173
164
176
123
61
65
160
151
151
136
167
163
248
166
198
176
250
197
244
214
241
Expenses
101
110
76
88
94
96
60
82
91
107
114
130
119
128
94
65
65
146
130
126
109
139
133
212
131
165
140
207
157
194
167
198
EBITDA
24
27
26
16
24
23
21
18
22
25
35
42
46
48
29
-4
0
14
21
25
27
29
31
35
35
33
35
42
40
50
47
43
Operating Profit %
19 %
19 %
25 %
15 %
20 %
19 %
25 %
15 %
19 %
18 %
23 %
24 %
27 %
27 %
22 %
-7 %
-1 %
9 %
12 %
16 %
19 %
17 %
18 %
14 %
20 %
16 %
19 %
16 %
20 %
20 %
21 %
17 %
Depreciation
5
5
5
5
5
5
5
6
6
6
6
6
8
8
8
8
8
8
8
8
8
8
8
8
8
9
9
9
10
10
10
10
Interest
3
3
3
3
3
3
3
3
3
3
3
3
5
5
5
4
5
5
6
6
6
6
6
6
5
5
4
5
6
6
6
5
Profit Before Tax
16
19
19
8
15
14
13
9
14
16
27
34
33
35
16
-16
-13
1
7
11
13
15
17
22
22
20
22
29
24
34
31
27
Tax
9
9
9
-5
8
5
5
2
7
5
5
11
9
12
7
-23
0
3
3
4
3
3
5
5
5
5
4
8
4
9
8
-6
Net Profit
7
10
9
13
8
10
8
6
7
11
21
23
24
23
9
6
-13
-2
4
6
9
12
12
17
17
14
18
20
21
25
24
33
EPS in ₹
0.85
1.19
1.11
1.57
0.92
1.17
0.90
0.76
0.83
1.30
2.53
2.73
2.78
2.72
1.07
0.73
-1.51
-0.24
0.44
0.73
1.10
1.39
1.36
2.04
1.95
1.67
2.15
2.40
2.31
2.84
2.59
3.58

Balance Sheet

Balance Sheet
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
656
493
503
559
608
812
860
880
1,034
1,153
1,362
Fixed Assets
370
291
279
281
281
457
438
412
437
533
656
Current Assets
248
157
169
208
219
309
377
411
534
555
638
Capital Work in Progress
13
8
8
18
42
7
11
33
30
35
122
Investments
0
29
28
27
26
27
22
11
11
12
351
Other Assets
272
166
187
232
260
321
389
424
556
573
0
Total Equity & Liabilities
656
493
503
559
608
812
860
880
1,034
1,153
1,362
Current Liabilities
200
147
122
143
145
195
197
255
332
324
353
Non Current Liabilities
162
91
97
94
115
206
193
164
166
189
224
Total Equity
294
255
285
322
348
411
470
461
536
640
786
Reserve & Surplus
285
246
276
314
340
402
462
452
499
615
776
Share Capital
9
9
9
9
9
9
9
9
9
9
9

Cash Flow

Cash Flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-9
1
0
2
-5
31
6
-39
29
5
Investing Activities
-97
-39
-17
-35
-43
-152
-27
-30
-52
-123
Operating Activities
61
74
32
50
40
90
45
23
50
82
Financing Activities
27
-33
-15
-13
-2
92
-12
-32
31
47

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
67.29 %
67.29 %
67.29 %
67.29 %
67.29 %
64.17 %
64.17 %
64.17 %
64.29 %
64.32 %
64.32 %
64.32 %
64.67 %
64.67 %
64.67 %
64.67 %
66.26 %
66.26 %
68.07 %
68.07 %
68.07 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.60 %
0.59 %
0.17 %
0.17 %
0.52 %
0.31 %
0.08 %
0.03 %
0.28 %
0.04 %
0.31 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.98 %
2.13 %
2.55 %
2.55 %
2.43 %
3.03 %
2.88 %
3.21 %
3.02 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
26.92 %
26.87 %
26.23 %
26.72 %
26.38 %
29.65 %
28.84 %
28.82 %
29.00 %
29.04 %
29.08 %
29.22 %
27.93 %
27.81 %
27.04 %
27.38 %
26.35 %
25.89 %
24.02 %
24.08 %
23.17 %
Others
5.79 %
5.84 %
6.47 %
5.99 %
6.33 %
6.18 %
6.98 %
7.00 %
6.70 %
6.64 %
6.01 %
5.88 %
5.25 %
5.22 %
5.23 %
5.09 %
4.87 %
4.78 %
4.76 %
4.61 %
5.43 %
No of Share Holders
19,878
25,601
24,608
24,959
27,516
26,638
26,491
26,526
25,537
24,653
25,246
25,341
30,140
31,780
33,136
34,973
35,332
33,652
33,009
34,378
32,397

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.2 0.25 0.25 0.25 0.3 0.3 0.3 0.4 0.4 0.00
Dividend Yield (%) 0.27 0.4 0.93 0.2 0.32 0.53 0.17 0.19 0.11 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
24 Sept 2021 DIVIDEND Dividend
0.30 /share
22 Sept 2021 167.60 157.70
23 Sept 2022 DIVIDEND Dividend
0.30 /share
22 Sept 2022 84.35 89.80
22 Sept 2023 DIVIDEND Dividend
0.30 /share
22 Sept 2023 84.40 121.50
06 Mar 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
06 Mar 2024 146.45 181.90
23 Sept 2024 DIVIDEND Dividend
0.40 /share
23 Sept 2024 209.90 368.65
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 312.55 351.20
08 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2024 294.60 305.90
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 205.15 200.02
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 262.50 270.37
09 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Aug 2025 228.91 223.95
22 Sept 2025 DIVIDEND Dividend
0.40 /share
22 Sept 2025 270.37 292.50
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 223.95 251.68
08 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2025 286.20 288.80
07 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Feb 2026 316.60 318.00
22 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
22 May 2026 400.20 426.10

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript4 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome7 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication9 days ago
Announcement under Regulation 30 (LODR)-Investor PresentationMay 23, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2026
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressMay 22, 2026
Statement Of Deviation & Variation For The Quarter Ended 31St March 2026May 22, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 22, 2026
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 22, 2026
Financial Results For The 4Th Quarter And Year Ended 31St March 2026May 22, 2026
Board Meeting Outcome for Approval Of Financial Results For The Fourth Quarter And Year Ended 31St March 2026May 22, 2026
Board Meeting Intimation for Approval Of Financial Results For The Quarter And Financial Year Ended 31St March 2026May 16, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 02, 2026
Confirmation Of Not- Falling Under Large Corporate CriteriaApr 30, 2026
Receipt Of Rectification Order By Income Tax DepartmentApr 29, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Demand Notice From Income Tax DepartmentMar 31, 2026
Closure of Trading WindowMar 25, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 20, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 10, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 09, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 09, 2026
Statement Of Deviation Or Variation For The Quarter Ended December 31 2025Feb 07, 2026
Financial Results For The Quarter Ended 31St December 2025Feb 07, 2026
Board Meeting Outcome for Outcome Of Board Meeting And Financial ResultsFeb 07, 2026
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 31St December 2025Jan 31, 2026
Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special WindowJan 17, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2026
Closure of Trading WindowDec 29, 2025
Announcement Under Regulation 30 - Investments In Subsidiary Company By Way Of Subscription Towards Rights IssueDec 26, 2025
Announcement under Regulation 30 (LODR)-AcquisitionDec 24, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 12, 2025
Announcement under Regulation 30 (LODR)-Credit RatingDec 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 26, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 13, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 12, 2025
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Nov 11, 2025
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Nov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 11, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 10, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 10, 2025
Statement Of Deviation Or Variation For The Quarter Ended September 30 2025Nov 08, 2025
Financial Results For The Quarter Ended 30Th September 2025Nov 08, 2025
Board Meeting Outcome for Outcome Of Board Meeting For Financial ResultsNov 08, 2025
Intimation Of Receipt Of Trading Approval From Stock ExchangesNov 07, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011Nov 06, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.08%
0
0.00%
0.00%
Quant Healthcare Fund Direct-Growth
8.86%
0
0.00%
-1.56%
Quant Small Cap Fund Direct Plan-Growth
0.25%
0
0.00%
-0.02%

Technical Indicators

RSI(14)
Neutral
38.19
ATR(14)
Less Volatile
18.81
STOCH(9,6)
Oversold
12.17
STOCH RSI(14)
Oversold
4.81
MACD(12,26)
Bearish
-5.30
ADX(14)
Weak Trend
19.23
UO(9)
Bearish
31.42
ROC(12)
Downtrend And Accelerating
-8.90
WillR(14)
Oversold
-88.32